To date, no specific treatment for CPIV3 and BPIV3 infection is available, and both viruses are reported to escape from host antiviral responses [18,20,21], whereas the potential of exogenous goat IFN-α against CPIV3 and BPIV3 infection has not been investigated to date. Here, IFNA2 is linked to infection.